tiprankstipranks
Galera Therapeutics (GRTX)
OTHER OTC:GRTX
US Market
GRTX
Galera Therapeutics
RESEARCH TOOLSreports

Galera Therapeutics (GRTX) Financial Statements

260 Followers

Galera Therapeutics Financial Overview

Galera Therapeutics's market cap is currently $3.11M. The company's EPS TTM is $; its P/E ratio is <0.01; Galera Therapeutics is scheduled to report earnings on ―, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 25Dec 24Dec 23Dec 22Dec 21
Income Statement
Total Revenue$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit$ 0.00$ -3.84M$ -259.00K$ -114.00K$ -778.00K
Operating Income$ -6.04M$ -20.16M$ -46.95M$ -51.23M$ -73.37M
EBITDA$ -6.04M$ -20.16M$ -70.24M$ -50.61M$ -72.56M
Net Income$ 149.05M$ -18.96M$ -59.08M$ -62.22M$ -80.53M
Balance Sheet
Cash & Short-Term Investments$ 6.38M$ 8.29M$ 18.26M$ 31.60M$ 71.22M
Total Assets$ 7.20M$ 10.10M$ 26.14M$ 44.04M$ 83.31M
Total Debt$ 0.00$ 151.05M$ 1.25M$ 44.00K$ 302.00K
Net Debt$ -6.38M$ -8.29M$ -17.01M$ -4.22M$ -19.56M
Total Liabilities$ 645.00K$ 153.77M$ 157.33M$ 153.22M$ 141.31M
Stockholders' Equity$ 6.55M$ -143.67M$ -131.19M$ -109.18M$ -58.00M
Cash Flow
Free Cash Flow$ -6.05M$ -12.14M$ -44.91M$ -43.45M$ -68.24M
Operating Cash Flow$ -6.05M$ -12.14M$ -44.85M$ -43.43M$ -67.96M
Investing Cash Flow$ 3.50M$ -46.00K$ 27.29M$ 23.99M$ 5.24M
Financing Cash Flow$ 635.00K$ 2.22M$ 31.50M$ 3.89M$ 66.71M
Currency in USD

Galera Therapeutics Earnings and Revenue History

Income Statement >

Galera Therapeutics Debt to Assets

Balance Sheet >

Galera Therapeutics Cash Flow

Cash Flow >

Galera Therapeutics Forecast EPS vs Actual EPS

Earnings >